JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA

JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA was reported 51 times

JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Echinocandin Antifungal [EPC] 1 0.0001
1 Bile Acid [EPC] 2 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Nucleoside Metabolic Inhibitor [EPC] 14 0.0001
4 Antimetabolite Immunosuppressant [EPC] 1 0.0000
5 Alkylating Drug [EPC] 11 0.0000
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
7 Azole Antifungal [EPC] 6 0.0000
8 Provitamin D2 Compound [EPC] 1 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
10 Aminoglycoside Antibacterial [EPC] 1 0.0000
11 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
12 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
13 Complement Inhibitor [EPC] 1 0.0000
14 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
15 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
16 BCL-2 Inhibitor [EPC] 1 0.0000
17 Fluoroquinolone Antibacterial [EPC] 2 0.0000
18 Glycopeptide Antibacterial [EPC] 1 0.0000
19 Topoisomerase Inhibitor [EPC] 1 0.0000
20 Nucleoside Analog Antiviral [EPC] 1 0.0000
21 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
22 Anti-epileptic Agent [EPC] 2 0.0000
23 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
24 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
25 Platinum-based Drug [EPC] 2 0.0000
26 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
27 Leukocyte Growth Factor [EPC] 1 0.0000
28 Mood Stabilizer [EPC] 1 0.0000
29 Retinoid [EPC] 1 0.0000
30 Corticosteroid [EPC] 5 0.0000
31 Opioid Agonist [EPC] 1 0.0000
32 Osmotic Laxative [EPC] 1 0.0000
33 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 1 0.0000